Medicolegal Review: Perinatal Effexor Lawsuits and Legal Strategies Adverse to Prescribing Obstetric Providers

Nathan Kirsch, Luis Pacheco, Amjad Hossain, John Phelps

Research output: Contribution to journalReview article

Abstract

Objectives This study was aimed to familiarize obstetricians with the legal environment surrounding Effexor lawsuits and emphasize the importance of documenting informed consent in the medical records when prescribing a medication that is being targeted for litigation. Study Design We used the LexisNexis legal search engine to review legal documents from Effexor-related cases and also used Google to search for Effexor-related lawsuits online, further researching these cases via publically available court records from district clerk offices. Finally, we conducted a year-by-year literature review from 1993 to 2017 to establish the history and evolution of scientific studies surrounding Effexor use during pregnancy. Results Litigation involving Effexor typically arises due to congenital cardiac birth defects in the neonate allegedly associated with maternal Effexor use in pregnancy. Medication manufacturers have employed a legal strategy termed the learned intermediary doctrine in an attempt to shift liability away from themselves and on to prescribing obstetricians. Manufacturers claim they adequately inform obstetricians of the risks and benefits of prescribing their product and it is the duty of the obstetrician to relay those risks and benefits to their patients. Conclusion To reduce the risk of liability exposure, obstetricians must adequately document informed consent in the medical records when prescribing medications to their pregnant patients.

Original languageEnglish (US)
Pages (from-to)E88-E91
JournalAJP Reports
Volume9
Issue number1
DOIs
StatePublished - Jan 19 2019

Fingerprint

Obstetrics
Jurisprudence
Medical Records
Consent Forms
Search Engine
Pregnancy
Informed Consent
Venlafaxine Hydrochloride
History
Mothers
Newborn Infant

Keywords

  • Effexor
  • informed consent
  • lawsuit
  • learned intermediary
  • liability
  • obstetric
  • pregnancy

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Obstetrics and Gynecology

Cite this

Medicolegal Review : Perinatal Effexor Lawsuits and Legal Strategies Adverse to Prescribing Obstetric Providers. / Kirsch, Nathan; Pacheco, Luis; Hossain, Amjad; Phelps, John.

In: AJP Reports, Vol. 9, No. 1, 19.01.2019, p. E88-E91.

Research output: Contribution to journalReview article

@article{64b1145f485740a9871387b3d5e87996,
title = "Medicolegal Review: Perinatal Effexor Lawsuits and Legal Strategies Adverse to Prescribing Obstetric Providers",
abstract = "Objectives This study was aimed to familiarize obstetricians with the legal environment surrounding Effexor lawsuits and emphasize the importance of documenting informed consent in the medical records when prescribing a medication that is being targeted for litigation. Study Design We used the LexisNexis legal search engine to review legal documents from Effexor-related cases and also used Google to search for Effexor-related lawsuits online, further researching these cases via publically available court records from district clerk offices. Finally, we conducted a year-by-year literature review from 1993 to 2017 to establish the history and evolution of scientific studies surrounding Effexor use during pregnancy. Results Litigation involving Effexor typically arises due to congenital cardiac birth defects in the neonate allegedly associated with maternal Effexor use in pregnancy. Medication manufacturers have employed a legal strategy termed the learned intermediary doctrine in an attempt to shift liability away from themselves and on to prescribing obstetricians. Manufacturers claim they adequately inform obstetricians of the risks and benefits of prescribing their product and it is the duty of the obstetrician to relay those risks and benefits to their patients. Conclusion To reduce the risk of liability exposure, obstetricians must adequately document informed consent in the medical records when prescribing medications to their pregnant patients.",
keywords = "Effexor, informed consent, lawsuit, learned intermediary, liability, obstetric, pregnancy",
author = "Nathan Kirsch and Luis Pacheco and Amjad Hossain and John Phelps",
year = "2019",
month = "1",
day = "19",
doi = "10.1055/s-0039-1678723",
language = "English (US)",
volume = "9",
pages = "E88--E91",
journal = "AJP Reports",
issn = "2157-6998",
publisher = "Thieme Medical Publishers",
number = "1",

}

TY - JOUR

T1 - Medicolegal Review

T2 - Perinatal Effexor Lawsuits and Legal Strategies Adverse to Prescribing Obstetric Providers

AU - Kirsch, Nathan

AU - Pacheco, Luis

AU - Hossain, Amjad

AU - Phelps, John

PY - 2019/1/19

Y1 - 2019/1/19

N2 - Objectives This study was aimed to familiarize obstetricians with the legal environment surrounding Effexor lawsuits and emphasize the importance of documenting informed consent in the medical records when prescribing a medication that is being targeted for litigation. Study Design We used the LexisNexis legal search engine to review legal documents from Effexor-related cases and also used Google to search for Effexor-related lawsuits online, further researching these cases via publically available court records from district clerk offices. Finally, we conducted a year-by-year literature review from 1993 to 2017 to establish the history and evolution of scientific studies surrounding Effexor use during pregnancy. Results Litigation involving Effexor typically arises due to congenital cardiac birth defects in the neonate allegedly associated with maternal Effexor use in pregnancy. Medication manufacturers have employed a legal strategy termed the learned intermediary doctrine in an attempt to shift liability away from themselves and on to prescribing obstetricians. Manufacturers claim they adequately inform obstetricians of the risks and benefits of prescribing their product and it is the duty of the obstetrician to relay those risks and benefits to their patients. Conclusion To reduce the risk of liability exposure, obstetricians must adequately document informed consent in the medical records when prescribing medications to their pregnant patients.

AB - Objectives This study was aimed to familiarize obstetricians with the legal environment surrounding Effexor lawsuits and emphasize the importance of documenting informed consent in the medical records when prescribing a medication that is being targeted for litigation. Study Design We used the LexisNexis legal search engine to review legal documents from Effexor-related cases and also used Google to search for Effexor-related lawsuits online, further researching these cases via publically available court records from district clerk offices. Finally, we conducted a year-by-year literature review from 1993 to 2017 to establish the history and evolution of scientific studies surrounding Effexor use during pregnancy. Results Litigation involving Effexor typically arises due to congenital cardiac birth defects in the neonate allegedly associated with maternal Effexor use in pregnancy. Medication manufacturers have employed a legal strategy termed the learned intermediary doctrine in an attempt to shift liability away from themselves and on to prescribing obstetricians. Manufacturers claim they adequately inform obstetricians of the risks and benefits of prescribing their product and it is the duty of the obstetrician to relay those risks and benefits to their patients. Conclusion To reduce the risk of liability exposure, obstetricians must adequately document informed consent in the medical records when prescribing medications to their pregnant patients.

KW - Effexor

KW - informed consent

KW - lawsuit

KW - learned intermediary

KW - liability

KW - obstetric

KW - pregnancy

UR - http://www.scopus.com/inward/record.url?scp=85063220343&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85063220343&partnerID=8YFLogxK

U2 - 10.1055/s-0039-1678723

DO - 10.1055/s-0039-1678723

M3 - Review article

AN - SCOPUS:85063220343

VL - 9

SP - E88-E91

JO - AJP Reports

JF - AJP Reports

SN - 2157-6998

IS - 1

ER -